Literature DB >> 2333512

Effect of phospholipase C-gamma overexpression on PDGF-induced second messengers and mitogenesis.

B Margolis1, A Zilberstein, C Franks, S Felder, S Kremer, A Ullrich, S G Rhee, K Skorecki, J Schlessinger.   

Abstract

Platelet-derived growth factor (PDGF) stimulates phospholipase C (PLC) activity and the phosphorylation of the gamma isozyme of PLC (PLC-gamma) in vitro and in living cells. The role of PLC-gamma in the phosphoinositide signaling pathway was addressed by examining the effect of overexpression of PLC-gamma on cellular responses to PDGF. Overexpression of PLC-gamma correlated with PDGF-induced tyrosine phosphorylation of PLC-gamma and with PDGF-induced breakdown of phosphatidylinositol 4,5-bisphosphate (PIP2). However, neither bradykinin- nor lysophosphatidic acid-induced phosphoinositide metabolism was enhanced in the transfected cells, suggesting that the G protein-coupled phosphoinositide responses to these ligands are mediated by other PLC isozymes. The enhanced PDGF-induced generation of inositol trisphosphate (IP3) did not enhance intracellular calcium signaling or influence PDGF-induced DNA synthesis. Thus, enzymes other than PLC-gamma may limit PDGF-induced calcium signaling and DNA synthesis. Alternatively, PDGF-induced calcium signaling and DNA synthesis may use biochemical pathways other than phosphoinositide metabolism for signal transduction.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2333512     DOI: 10.1126/science.2333512

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  54 in total

1.  Src homology region 2 domains direct protein-protein interactions in signal transduction.

Authors:  M F Moran; C A Koch; D Anderson; C Ellis; L England; G S Martin; T Pawson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  SH2 domains of the p85 alpha subunit of phosphatidylinositol 3-kinase regulate binding to growth factor receptors.

Authors:  C J McGlade; C Ellis; M Reedijk; D Anderson; G Mbamalu; A D Reith; G Panayotou; P End; A Bernstein; A Kazlauskas
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

3.  Mutated alpha subunit of the Gq protein induces malignant transformation in NIH 3T3 cells.

Authors:  G Kalinec; A J Nazarali; S Hermouet; N Xu; J S Gutkind
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

Review 4.  Inositol-lipid-specific phospholipase C isoenzymes and their differential regulation by receptors.

Authors:  S Cockcroft; G M Thomas
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

5.  Platelet-derived growth factor activates phospholipase D and chemotactic responses in vascular smooth muscle cells.

Authors:  C J Welsh; K Schmeichel; K McBride
Journal:  In Vitro Cell Dev Biol       Date:  1991-05

6.  Platelet-derived growth factor (PDGF)-induced disulfide-linked dimerization of PDGF receptor in living cells.

Authors:  W Li; J Schlessinger
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

7.  Transmembrane signalling at the epidermal growth factor receptor. Positive regulation by the C-terminal phosphotyrosine residues.

Authors:  M Magni; A Pandiella; K Helin; J Meldolesi; L Beguinot
Journal:  Biochem J       Date:  1991-07-15       Impact factor: 3.857

8.  A protein that is highly related to GTPase-activating protein-associated p62 complexes with phospholipase C gamma.

Authors:  M C Maa; T H Leu; B J Trandel; J H Chang; S J Parsons
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

9.  Mitogenic signaling from the egf receptor is attenuated by a phospholipase C-gamma/protein kinase C feedback mechanism.

Authors:  P Chen; H Xie; A Wells
Journal:  Mol Biol Cell       Date:  1996-06       Impact factor: 4.138

10.  eps15, a novel tyrosine kinase substrate, exhibits transforming activity.

Authors:  F Fazioli; L Minichiello; B Matoskova; W T Wong; P P Di Fiore
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.